Congratulations Dr. Karla Williams!  She is the recipient of the TBCRU Post-doctoral fellowship award ($25,000/year).  Her co-supervisors are Dr. Ann Chambers and Dr. Hon Leong.  She is conducting research to identify breast cancer microparticles present in patient plasma to develop a “liquid biopsy” for localized and recurrent breast cancer. By using antibodies specific to HER2+ or ER/PR+ breast cancer subtype patients, breast cancer microparticles present in patient plasma can be readily enumerated by nanoscale flow cytometry. This will allow for a quantification of tumor burden and may be useful in monitoring patients during therapy or for detection of subsequent recurrences.